Divanshi Suryavanshi et al. 2025. INSULYSIN INHIBITORS AS NOVEL ANTI-DIABETIC AGENTS: FROM COMPUTATIONAL DESIGN TO PRE-CLINICAL VALIDATION. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 1242–1257. DOI:https://doi.org/10.53555/npva0c18.